Home/Publication/JAFCO et al in Gut Microbiome-based Drug Development
JAFCO et al in Gut Microbiome-based Drug Development 

12 Sep 2025

US$ 20.00

JAFCO Group Co Ltd, JIC Venture Growth Investments, Keio Innovation Initiative, Mizuho Capital, SMBC Venture Capital...

Price / article: US$20.00
OR existing subscriber
Related Publications

Kotak Alternate Asset Managers Ltd is close to reaching the target of its Kotak Yield & Growth Fund, having raised ......

Nuveen, a wholly owned subsidiary of Teachers Insurance and Annuity Association of America, or better known as TIAA ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.